Status:
COMPLETED
Patient Education in Children With Functional Gastrointestinal Disorders
Lead Sponsor:
Karolinska Institutet
Conditions:
Functional Gastrointestinal Disorders
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
This pilot-study aims to evaluate the effect size and feasibility of patient education for children and adolescents (age 8-17 years) with pain-predominant functional gastrointestinal disorders (irrita...
Detailed Description
The patient education will be provided in a group setting and the children will participate along with one of their parents. Education consists of 2-hour long group sessions, given at 2 different occa...
Eligibility Criteria
Inclusion
- Children and adolescents between 8-17 years (until their 18th birthday) who have been diagnosed with any of the diagnoses irritable bowel syndrome, functional dyspepsia or functional abdominal pain according to the Rome III criteria.
- Blood samples, with normal outcome, in terms of complete blood count (CBC), Erythrocyte Sedimentation Rate (ESR), Anti-tissue Transglutaminase Antibody (tTG), and dipstick urinalysis. Faecal Calprotectin should be measured if diarrhea is present.
Exclusion
- Insufficient skills in the Swedish language.
- Severe psychiatric comorbidity (as suicidality, psychosis etc).
- Severe somatic comorbidity.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04294420
Start Date
May 1 2020
End Date
December 1 2021
Last Update
December 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinka Institutet
Stockholm, Sweden, 17177